Global Artificial Pancreas Device System Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2015 Future Market Insights www.futuremarketinsights.com sales@futuremarketinsights.com Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Research Capabilities Sector Coverage Customized Research Syndicated Research Investment Research Social Media Research Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Customized Research Subscription Information Syndicated Research For detailed subscription information please contact Investment Research T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Social Media Research Hari. T (Sr. Manager - Global Business Development) Email: hari.t@futuremarketinsights.com Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Report Description Report Description Pancreas is one of the major endocrine gland which secretes hormones released directly into the blood. Pancreas is around 6 inches long located in the abdominal cavity. Pancreas produce the vital hormones of insulin, pancreatic polypeptide, glucagon and somatostatin. Pancreas aid in digestion and absorption processes by secreting the pancreatic juice which contains digestive enzymes. The Artificial Pancreas Device System is used in the treatment of Type 1 Diabetes. Type 1 diabetes patients require multiple doses of insulin in a day and all-round the year. The Artificial Pancreas Device System is also referred to as the closed-loop system or autonomous system for glycemic control or bionic pancreas. The Artificial Pancreas Device System simulates the glucose regulation function of a healthy pancreas. The continuous glucose monitoring is done by placing the sensor subcutaneously to measure the glucose level in the fluid around the cells. A transmitter sends information of glucose level estimates and their rate of change to the receiver. Control algorithm software embedded in an external controller performs mathematical calculations to send dosing instruction to the insulin infusion pumps, computer or smartphone. Depending on the dosing instructions, the insulin infusion pump regulates the level of insulin delivery to the subcutaneous tissue. Browse Full Report@ http://www.futuremarketinsights.com/reports/artificial-pancreasdevice-system-market Artificial Pancreas Device System Market: Drivers & Restraints The Food and Drug Administration (FDA) is collaborating with private and government research institutions to improvise clinical studies and accelerate the development of the Report Description Report Description the FDA released a document on requirements of clinical studies and premarket approval applications for the production Artificial Pancreas Device Systems. This will encourage the manufacturing of Artificial Pancreas Device Systems and drive the growth of the global Artificial Pancreas Device System market. The patients need to calibrate the continuous glucose monitor at equal intervals. Also, the continuous glucose monitoring sensors are subjected to biofouling and fibrosis when they are placed subcutaneously which alters the productivity of sensors. The FDA has identified issues in the components and software of insulin infusion pumps. The insulin used currently in the Artificial Pancreas Device Systems takes longer duration of time to completely absorb. Such factors related to Artificial Pancreas Device Systems could potentially hamper the growth of the global Artificial Pancreas Device Systems market. Artificial Pancreas Device System Market: Segmentation Artificial Pancreas Device System market is classified on the basis product type and geography. Based on product type, the global Artificial Pancreas Device System market is segmented into the following: Threshold Suspend Device System Control-to-Range (CTR) System Control -to-Target (CTT) System Report Description Report Description Artificial Pancreas Device System Market: Overview The concentration of glucose in the blood of the patient is very dynamic and is affected by the patient’s physical activity and diet. The Artificial Pancreas Device System helps in the sustenance of life of type 1 diabetes patients. The Artificial Pancreas Device System does the function of beta cells of a healthy pancreas. Type 1 diabetes patient have to closely monitor blood glucose levels in order to avoid hyperglycemia and hypoglycemia which leads to long-term diabetes complications such as seizures, coma and even death. Thus, blood glucose monitoring on a daily basis is essential and the Artificial Pancreas Device System is the solution to it. Request Report Sample with TOC@ http://www.futuremarketinsights.com/reports/sample/rep-gb-974 Artificial Pancreas Device System Market: Region-wise Outlook Depending on geographic regions, global Artificial Pancreas Device System market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan, Japan, and Middle East & Africa. India, China, USA, Indonesia, Pakistan and Japan are the top six countries with the highest number of estimated cases of diabetes. As a result, Asia Pacific and North America are anticipated to be the potential markets for the global Artificial Pancreas Device System market players. Report Description Report Description Artificial Pancreas Device System Market: Key Players Some of the key market players in global Artificial Pancreas Device System market are Pancreum, LLC, Medtronic, Inc. and JDRF. In the near future, the global Artificial Pancreas Device System manufacturers have to develop products which will not only monitor but also adjust the blood glucose levels rapidly without the need of intervention of the patient. Thank You! To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For other queries contact: Mr. Sudip Saha Future Market Insights: 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 | D: +1-845-579-5705
Pancreas is one of the major endocrine gland which secretes hormones released directly into the blood. Pancreas is around 6 inches long located in the abdominal cavity. Pancreas produce the vital hormones of insulin, pancreatic polypeptide, glucagon and somatostatin. Pancreas aid in digestion and absorption processes by secreting the pancreatic juice which contains digestive enzymes. The Artificial Pancreas Device System is used in the treatment of Type 1 Diabetes. Type 1 diabetes patients require multiple doses of insulin in a day and all-round the year. The Artificial Pancreas Device System is also referred to as the closed-loop system or autonomous system for glycemic control or bionic pancreas. The Artificial Pancreas Device System simulates the glucose regulation function of a healthy pancreas. The continuous glucose monitoring is done by placing the sensor subcutaneously to measure the glucose level in the fluid around the cells. A transmitter sends information of glucose level estimates and their rate of change to the receiver. Control algorithm software embedded in an external controller performs mathematical calculations to send dosing instruction to the insulin infusion pumps, computer or smartphone. Depending on the dosing instructions, the insulin infusion pump regulates the level of insulin delivery to the subcutaneous tissue.
© Copyright 2024 Paperzz
